• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Sun Genomics Nabs $8.65M to Scale Personalized Probiotic Solutions

Share:

July 14, 2020

Highlights on this story:
  • Sun Genomics raises $8.65M in Series A funding to scale direct to consumer personalized probiotic solutions based on whole-genome sequencing diagnostics.
  • Flagship product Floré, a microbiome test, and gut probiotics solution utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles.

Sun Genomics, a San Diego, CA-based direct-to-consumer custom probiotics and gut health company, announced it has raised $8.65 million in Series A funding led by Pangaea Ventures with additional investments from Danone Manifesto Ventures, SOSV, Human Longevity, and Nascita Ventures. Chris Erickson, Founding General Partner at Pangaea Ventures, has joined as a new Board member. Sun Genomics is the first to market with completely personalized probiotic solutions based on whole-genome sequencing diagnostics.

What is the Microbiome?

The microbiome is the collection of all the microbes and their corresponding set of genes. Sun Genomics focuses on the microbiome located in the gut. A common misconception is that all these microbes are bad for you, but that is not true; microbes play an integral role in aiding the body’s immunological, nutritional, and metabolic functions.

Custom Probiotics For A Healthy Gut

Founded in 2016 by Sunny Jain when his son started suffering from GI distress, Sun Genomics is a first-of-its-kind, custom probiotics startup with the mission to improve gut health through personalized science. With the release of its flagship product Floré, a microbiome test and gut probiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles.

How Floré Gut Test + Precision Probiotics Works

Sun Genomics Nabs $8.65M to Scale Personalized Probiotic Solutions
Sun Genomics analyze your gut microbiota and use the results to create your custom probiotics in a four-step process:

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

1. Order gut health test

2. Complete sampling

3. Analyze gut sample

4. Receive custom probiotics straight to your front door

Every custom probiotic is personalized designed to address your specific needs.

Floré Tots

The company also offers Floré Tots, which is available for kids up to age 12 and comes in an easy digestive powder to mix with their favorite drink. Since Sun Genomics’ Seed funding in October of 2019, the company has seen consistent growth in headcount and revenue. This additional financing brings the total funding to $11.75 million to date.

Results/Outcomes

Floré customers have reported these improvements in their digestive health:

– Relief from bloating, gas, and constipation

– Increased energy

– Regularity of bowel movements

– Improved digestion

– Better food tolerance

– Increased immunity

Expansion Plans

With the global human microbiome market expected to reach $1.4 billion by 2020, Sun Genomics will use this round of funding to support its growth in the custom probiotics market, scale delivery across the U.S., enter international markets, and propel the publication of its studies in partnership with leading academic institutions.

“As we continue to understand the connection between the microbes in our gut and immune system dysfunction, consumers are becoming increasingly interested in their own personal microbiome, seeking solutions to gut-related issues,” said Sunny Jain, CEO and founder of Sun Genomics. “We are building the world’s largest longitudinal dataset to better understand gut health, allowing us to custom design probiotics for the exact needs of each and every customer. Today’s announcement is a clear indicator in the progress we have made and our future potential. We are excited to work with our new partners to reach even more consumers.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • UK Company Offers Free Remote Consultation Training Programme for NHS GPSUK Company Offers Free Remote Consultation Training Programme for NHS GPS
  • US Health Care Companies Begin Exploring Blockchain TechnologiesUS Health Care Companies Begin Exploring Blockchain Technologies
  • XRHealth Partners With Allscripts To Provide Integrated Virtual Reality/Augmented Reality PlatformsXRHealth Partners With Allscripts To Provide Integrated Virtual Reality/Augmented Reality Platforms
  • Diversity in clinical trials defines good science and better medicineDiversity in clinical trials defines good science and better medicine
  • Rural Health Startup Homeward Emerges with $20M to Support Rural CommunitiesRural Health Startup Homeward Emerges with $20M to Support Rural Communities
  • Pharmaceutical Packaging Market is Registering a Substantial CAGR of 7.20% During 2019-2026 | 3M, BD, CCL Industries, Mckesson, Westrock, AptargroupPharmaceutical Packaging Market is Registering a Substantial CAGR of 7.20% During 2019-2026 | 3M, BD, CCL Industries, Mckesson, Westrock, Aptargroup
  • Ambulnz (dba DocGo), a Leading Provider of Last-Mile TeleHealth and Integrated Medical Mobility Services, Announces Agreement to Become Publicly Traded via Merger with Motion Acquisition Corp.Ambulnz (dba DocGo), a Leading Provider of Last-Mile TeleHealth and Integrated Medical Mobility Services, Announces Agreement to Become Publicly Traded via Merger with Motion Acquisition Corp.
  • Encompass Health announces definitive agreement to acquire Birmingham‑based Alacare Home Health & HospiceEncompass Health announces definitive agreement to acquire Birmingham‑based Alacare Home Health & Hospice

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications